House Committee Examines Bills That Would Make Drug Pricing More Transparent
Minnesota Legislature Approves First Ever Bill Regulating Pharmacy Benefit Managers
GlaxoSmithKline is the Perfect Example of a Company Engaging in Anti-Competitive Behavior and Price
Judge Picks Six Witnesses, Sets Hearing Date to Hear Criticisms of CVS-Aetna Merger
FTC Commissioner Rohit Chopra Says Rebate Walls and PBMs Need to Be Looked At and Hurt Competition
New Bill Would Require the FTC to Investigate Competition in the PBM Market
Senate Judiciary Committee Examines Patent Abuse, Anticompetitive Behavior That Contributes to Risin
Consumer Groups Submit Letter to Senate Leaders in Support of the CREATES Act
Ohio State Representatives Propose Stricter Oversight of PBMs and Medicaid
States Are Taking Aggressive Steps To Lower Drug Prices By Regulating Drug Companies and PBMs
